ABUS
Arbutus Biopharma Corp
4.30$
-4.2%
vs. previous close
Closing price · As of: Oct 7, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 1998 | 1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 43.1% | 70.2% | 77.6% | 73.6% | 73.1% | 79.0% | 69.9% | 59.1% | 91.7% | 93.8% | 64.5% | 59.1% | 85.2% | 84.3% | 97.4% | 98.1% | 98.5% | 25.8% | 48.1% | 54.6% | 56.7% | 88.9% | 93.2% | 78.6% | 77.3% | 91.4% | 96.7% | 99.8% | |
| 5.0% | 37.9% | 6.3% | 37.9% | 38.5% | 70.1% | 60.8% | 56.7% | 80.6% | 85.1% | 50.9% | 55.5% | 58.7% | 65.6% | 89.4% | 95.8% | 61.1% | 23.4% | 8.5% | 22.9% | 16.2% | 30.1% | 38.1% | 53.4% | 15.7% | 18.2% | 27.6% | 19.0% | |
| 40.8% | 68.1% | 73.7% | 70.4% | 71.7% | 77.3% | 60.8% | 56.7% | 80.6% | 85.1% | 62.0% | 55.5% | 58.7% | 65.6% | 89.4% | 95.8% | 94.9% | 25.5% | 47.3% | 53.3% | 54.7% | 86.1% | 89.9% | 76.0% | 75.2% | 87.3% | 93.1% | 96.7% | |
| 1.3% | 1.8% | 2.5% | 3.0% | 1.0% | 0.8% | 4.4% | 1.4% | 10.0% | 7.4% | 2.0% | 3.0% | 17.8% | 8.7% | 6.6% | 0.5% | 2.1% | 0.2% | 0.1% | 0.2% | 0.6% | 1.1% | 1.0% | 0.4% | 0.7% | 1.2% | 1.8% | 1.8% | |
| 0.0% | 0.0% | 0.6% | 0.0% | 0.0% | 0.0% | 0.7% | 0.0% | 0.0% | 0.9% | 0.3% | 0.0% | 0.7% | 0.0% | -3.9% | 1.5% | 0.0% | 0.1% | 0.0% | 0.0% | – | – | -2.3% | -2.2% | -1.5% | -1.2% | – | – | |
| – | – | 7.5% | 4.1% | 7.0% | 8.1% | 8.3% | 5.1% | 8.3% | 6.2% | 5.1% | 6.4% | 14.9% | 15.7% | 2.6% | 1.9% | 1.5% | 0.4% | 2.5% | 5.1% | 4.5% | 8.2% | 5.1% | 2.9% | 2.6% | – | – | – | |
| – | – | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 22.8% | 8.8% | 10.3% | 9.9% | 0.0% | – | – | – | – | – | – | |
| 1.3% | 1.8% | 2.5% | 3.0% | 1.0% | 0.8% | 4.4% | 1.4% | 0.0% | 0.0% | 30.4% | 34.5% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 49.5% | 36.0% | 24.7% | 19.2% | – | – | – | – | – | – | – | |
| 8.9% | 6.7% | 7.7% | 9.0% | 14.8% | 14.5% | 125.5% | 200.0% | 97.4% | 26.0% | 9.6% | 15.5% | 48.9% | 62.0% | 22.2% | 17.5% | 25.5% | 23.1% | 26.4% | 23.1% | 12.1% | 31.1% | 25.6% | 17.1% | 30.0% | 26.6% | 26.1% | 19.1% | |
| 5.2% | 4.6% | 5.9% | 3.8% | 9.0% | 8.9% | 26.5% | 11.9% | 96.3% | 26.0% | 9.6% | 15.5% | 38.7% | 49.9% | 20.8% | 17.5% | 12.2% | 1.5% | 3.8% | 5.0% | 4.9% | 7.4% | 7.0% | 5.5% | 16.8% | 15.6% | 11.9% | 6.3% | |
| – | 0.1% | 0.2% | 0.2% | 0.3% | 0.8% | 1.9% | 0.3% | 1.4% | 0.6% | 6.9% | 0.0% | 0.0% | 0.0% | 5.7% | 3.4% | 1.2% | 0.9% | 2.4% | 2.5% | – | 0.3% | 0.3% | 0.2% | 0.2% | 0.3% | 0.4% | 0.6% | |
| – | – | 5.7% | 3.6% | 8.1% | 7.3% | 2.3% | 7.0% | 5.2% | 1.3% | 1.2% | 4.8% | 14.5% | 9.2% | 1.5% | 1.7% | 1.7% | 0.4% | 1.2% | 0.8% | 1.4% | 2.3% | 2.2% | 1.6% | 1.8% | 2.2% | 1.8% | 1.2% | |
| – | – | 0.2% | 0.4% | 0.3% | 1.6% | 78.3% | 186.7% | 1.1% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 4.3% | 5.1% | – | – | – | – | – | – | – | – | |
| 91.1% | 93.3% | 92.3% | 91.0% | 85.2% | 85.5% | -25.5% | -100.0% | 2.6% | 74.0% | 90.4% | 84.5% | 51.1% | 38.0% | 77.8% | 82.5% | 74.5% | 76.9% | 73.6% | 76.9% | 87.9% | 68.9% | 74.4% | 82.9% | 70.0% | 73.4% | 73.9% | 80.9% | |
| -129.8% | -104.2% | -117.4% | -74.8% | -149.6% | -280.9% | -431.0% | -1,034.8% | -2,776.1% | -804.4% | -411.6% | -505.1% | -1,184.0% | -1,850.1% | -437.7% | -232.9% | -174.2% | -37.5% | -236.0% | -311.2% | -353.3% | -919.2% | -763.0% | -554.7% | -616.0% | -884.1% | -1,022.4% | -1,458.6% | |
| 13.7% | 9.8% | 15.2% | 7.5% | 12.3% | 14.0% | 18.7% | 41.7% | 63.9% | 19.2% | 19.2% | 24.6% | 49.2% | 82.6% | 27.2% | 21.3% | 19.0% | 6.4% | 19.2% | 23.1% | 24.3% | 54.1% | 55.3% | 52.0% | 77.2% | 114.9% | 140.9% | 202.5% |
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.